Luke Crowe

Luke Crowe has extensive experience in various roles within the pharmaceutical and healthcare industries. Luke currently serves as the Director of Global Portfolio Innovation at Cochlear, where Luke is responsible for creating and defining the company's Connected Health strategy. Prior to Cochlear, Luke held leadership positions at Merck Sharp & Dohme, sanofi-aventis, and Bayer Pharmaceuticals. Luke has a strong background in marketing, market research, sales, and product management. Luke holds a Graduate Diploma in Management and a Bachelor of Technology from Macquarie University.